Health Care & Life Sciences » Biotechnology | Genetic Signatures Ltd.

Genetic Signatures Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
684.30
1,043.30
1,825.00
2,037.70
2,840.10
Cost of Goods Sold (COGS) incl. D&A
1,688.70
2,776.60
4,808.30
5,258.20
6,338.50
Gross Income
1,004.40
1,733.30
2,983.30
3,220.50
3,498.30
SG&A Expense
838.70
739.00
696.00
1,724.90
2,138.60
EBIT
1,843.10
2,472.30
3,679.30
-
5,636.90
Unusual Expense
219.90
676.30
119.30
-
-
Non Operating Income/Expense
289.30
520.60
749.70
7.80
9.70
Pretax Income
2,336.70
3,628.20
4,456.50
4,686.30
5,397.20
Income Tax
608.20
969.10
1,429.90
2,015.60
2,143.40
Consolidated Net Income
1,728.50
2,659.10
3,026.60
2,670.60
3,253.80
Net Income
1,728.50
2,659.10
3,026.60
2,670.60
3,253.80
Net Income After Extraordinaries
1,728.50
2,659.10
3,026.60
2,670.60
3,253.80
Net Income Available to Common
1,728.50
2,659.10
3,026.60
2,670.60
3,253.80
EPS (Basic)
0.12
0.05
0.04
0.03
0.03
Basic Shares Outstanding
-
-
-
96,056.40
103,954.60
EPS (Diluted)
-
-
-
0.03
0.03
Diluted Shares Outstanding
-
-
-
96,056.40
103,954.60
EBITDA
1,739.20
2,266.80
3,280.00
4,466.70
5,005.10
Non-Operating Interest Income
15.60
41.00
91.80
251.30
230.00

About Genetic Signatures

View Profile
Address
7 Eliza Street
Newtown New South Wales (NSW) 2042
Australia
Employees -
Website http://www.geneticsignatures.com
Updated 07/08/2019
Genetic Signatures Ltd. engages in the research and commercialization of identifying individual genetic signatures to identify diseases and disabilities. Its molecular diagnostics, 3Base, provides high-volume hospital and pathology laboratories the ability to screen wide array of infectious pathogens. The firm also designs and manufactures suite of real-time polymerase chain reaction based products for the routine detection of infectious diseases under the EasyScreen brand.